Filters

Marcus E Kleber, Ferdinand Van't Hooft, Jesper R Gadin, Azin Kheirkhah, Annette Peters, Winfried März, Markus Loeffler, Christian Gieger, Markus Scholz, Florian Kronenberg, Joachim Thiery, Graciela E Delgado, Lukas Forer, Hubert Scharnagl, Angela Silveira, Ralph Burkhardt, Stefanie M Hauck, Holger Kirsten, Janne Pott

Biology of sex differences 2024;15(1):26

Free Full Text

Abstract

New frontiers in structural flavoenzymology.

Andrea Mattevi, Luigi De Colibus

Current opinion in structural biology 2007;16(6):722-8

Full Text

Abstract

Modulating the Molybdenum Coordination Sphere of Escherichia coli Trimethylamine N-Oxide Reductase.

Chantal Iobbi-Nivol, Silke Leimkühler, Ulla Wollenberger, Lothar Jänsch, Manfred Nimtz, Christian Teutloff, Biljana Mitrova, Benjamin R Duffus, Paul Kaufmann

Biochemistry 2018;57(7):1130-1143

Full Text

Abstract

Potent mechanism-based inhibition of human CYP3A in vitro by amprenavir and ritonavir: comparison with ketoconazole.

L L von Moltke, A L Durol, S X Duan, D J Greenblatt

European journal of clinical pharmacology 2000;56(3):259-61

Full Text

Abstract

The in-vivo effects of sho-saiko-to, a traditional Chinese herbal medicine, on two cytochrome P450 enzymes (1A2 and 3A) and xanthine oxidase in man.

Junji Saruwatari, Kazuko Nakagawa, Junichi Shindo, Shinobu Nachi, Hirotoshi Echizen, Takashi Ishizaki

The Journal of pharmacy and pharmacology 2004;55(11):1553-9

Full Text

Abstract

Oral administration of a low dose of midazolam (75 microg) as an in vivo probe for CYP3A activity.

Chin B Eap, Thierry Buclin, Gianni Cucchia, Daniele Zullino, Elisabeth Hustert, Gabriela Bleiber, Kerry Powell Golay, Anne-Catherine Aubert, Pierre Baumann, Amalio Telenti, Reinhold Kerb

European journal of clinical pharmacology 2004;60(4):237-46

Full Text

Abstract

Verapamil: metabolism in cultures of primary human coronary arterial endothelial cells.

Jurgen Borlak, Markus Walles, Karsten Levsen, Thomas Thum

Drug metabolism and disposition: the biological fate of chemicals 2004;31(7):888-91

Full Text

Abstract

Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).

R H Mathijssen, R J van Alphen, J Verweij, W J Loos, K Nooter, G Stoter, A Sparreboom

Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2182-94

Full Text

Abstract

Results: 1 – 15 / 44

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Oxidoreductases, N-Demethylating""[mesh_terms]

Trimethylamine N-oxide metabolism by abundant marine heterotrophic bacteria.

Multidisciplinary Insights into the Structure-Function Relationship of the CYP2B6 Active Site.

Microsomal protein concentration modifies the apparent inhibitory potency of CYP3A inhibitors.

Human and Arabidopsis alpha-ketoglutarate-dependent dioxygenase homolog proteins-New players in important regulatory processes.

A biochemical approach to study the role of the terminal oxidases in aerobic respiration in Shewanella oneidensis MR-1.

Catabolic pathways and biotechnological applications of microbial caffeine degradation.

Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy.

Sex and statin-related genetic associations at the PCSK9 gene locus: results of genome-wide association meta-analysis.

New frontiers in structural flavoenzymology.

Modulating the Molybdenum Coordination Sphere of Escherichia coli Trimethylamine N-Oxide Reductase.

Potent mechanism-based inhibition of human CYP3A in vitro by amprenavir and ritonavir: comparison with ketoconazole.

The in-vivo effects of sho-saiko-to, a traditional Chinese herbal medicine, on two cytochrome P450 enzymes (1A2 and 3A) and xanthine oxidase in man.

Oral administration of a low dose of midazolam (75 microg) as an in vivo probe for CYP3A activity.

Verapamil: metabolism in cultures of primary human coronary arterial endothelial cells.

Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).

Results for
""Oxidoreductases, N-Demethylating""[mesh_terms]